organization

INS

Instituto Nacional de Saúde
  • project . 2020 - 2023
    Funder: EC Project Code: 847465
    Overall Budget: 9,969,010 EURFunder Contribution: 9,969,010 EUR
    Open Access mandate for Publications and Research Data
    Partners: FZB, IFP CHIRIL DRAGANIUC, Aurum Institute, NCTBLD, University of Antwerp, LMU, WHC, Institutul de Pneumoftiziologie "Marius Nasta", SWISS TPH, INS

    Tuberculosis is a leading cause of morbidity and mortality worldwide. Current TB treatments are inadequate, requiring patients closely adhere to multi-drug regimens that are long, complex, and often poorly tolerated. These concerns are greatly magnified in rifampicin-re...

  • project . 2015 - 2019
    Funder: EC Project Code: 643558
    Overall Budget: 7,999,920 EURFunder Contribution: 7,993,660 EUR
    Open Access mandate for Publications
    Partners: IGTP, Stockholm University, Kings College London, AOUP, Karolinska Institutet Innovations (Sweden), Department of Health, MIKROBIOLOGICKY USTAV AV CR V.V.I, SPONGE UK LIMITED, LIO, INS...

    Tuberculosis (TB) is a global health problem, killing 1.5 million of people every year. The only currently available vaccine, Mycobacterium bovis BCG, is effective against severe childhood forms, but it demonstrates a variable efficacy against the pulmonary form of TB i...

  • project . 2010 - 2015
    Funder: EC Project Code: 241904
    Open Access mandate for Publications Special Clause 39
    Partners: INSERM, UCL, UKRI, UPMC, CNRST, GENEART, IRSICAIXA, ST GEORGE'S HOSPITAL MEDICAL SCHOOL, Imperial, University of Regensburg...
  • project . 2016 - 2020
    Funder: EC Project Code: 681032
    Overall Budget: 28,135,600 EURFunder Contribution: 22,188,500 EUR
    Open Access mandate for Publications
    Partners: Imperial, University of Regensburg, UGA, UZH, INMI, UCL, EATG, IDIBAPS, INSERM, MUI...

    Many HIV vaccine concepts and several efficacy trials have been conducted in the prophylactic and therapeutic fields with limited success. There is an urgent need to develop better vaccines and tools predictive of immunogenicity and of correlates of protection at early ...

Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue